Vertex Pharmaceuticals loss widens
Cambridge-based Vertex Pharmaceuticals Inc. said yesterday its fourth-quarter loss widened as development costs increased and revenue dropped sharply.
Liberty Global Inc. says its loss widened significantly last quarter on surging costs and write-downs.